Znaczenie inhibitorów aromatazy w leczeniu chorych na raka piersi

Per Eystein Lønning, Emilio Bajetta, Robin Murray, Michele Tubiana-Hulin, Peter D Eisenberg, Elizabeth Mickiewicz, Luigi Celio, Paula Pitt, Monica Mita, Neil K Aaronson, Camilla Fowst, Alexei Arkhipov, Enrico di Salle, Anna Polli, Giorgio Massimini, None, Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial Journal of Clinical Oncology. ,vol. 18, pp. 2234- 2244 ,(2000) , 10.1200/JCO.2000.18.11.2234

Early Breast Cancer Trialists' Collaborative Group, None, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials The Lancet. ,vol. 365, pp. 1687- 1717 ,(2005) , 10.1016/S0140-6736(05)66544-0

R Jakesz, M Gnant, R Griel, C Tausch, H Samonigg, W Kwasny, E Kubista, M Stierer, G Luschin, E Rüecklinger, M Mittlböck, Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8. Cancer Research. ,vol. 69, pp. 14- ,(2009) , 10.1158/0008-5472.SABCS-14

Paolo Carlini, Emilio Bria, Diana Giannarelli, Gianluigi Ferretti, Alessandra Felici, Paola Papaldo, Alessandra Fabi, Cecilia Nisticò, Serena Di Cosimo, Enzo Maria Ruggeri, Michele Milella, Marcella Mottolese, Edmondo Terzoli, Francesco Cognetti, New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma Cancer. ,vol. 104, pp. 1335- 1342 ,(2005) , 10.1002/CNCR.21339

Jae Hong Seo, Yeul Hong Kim, Jun Suk Kim, Meta-analysis of pre-operative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer. Cancer Chemotherapy and Pharmacology. ,vol. 63, pp. 261- 266 ,(2009) , 10.1007/S00280-008-0735-5

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. The New England Journal of Medicine. ,vol. 361, pp. 766- 776 ,(2009) , 10.1056/NEJMOA0810818

Federica Cuppone, Emilio Bria, Sunil Verma, Kathleen I. Pritchard, Sonal Gandhi, Paolo Carlini, Michele Milella, Cecilia Nisticò, Edmondo Terzoli, Francesco Cognetti, Diana Giannarelli, Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials. Cancer. ,vol. 112, pp. 260- 267 ,(2008) , 10.1002/CNCR.23171

Jürgen Geisler, Per Eystein Lønning, None, Aromatase inhibition: translation into a successful therapeutic approach. Clinical Cancer Research. ,vol. 11, pp. 2809- 2821 ,(2005) , 10.1158/1078-0432.CCR-04-2187

Mitch Dowsett, Jack Cuzick, Jim Ingle, Alan Coates, John Forbes, Judith Bliss, Marc Buyse, Michael Baum, Aman Buzdar, Marco Colleoni, Charles Coombes, Claire Snowdon, Michael Gnant, Raimund Jakesz, Manfred Kaufmann, Francesco Boccardo, Jon Godwin, Christina Davies, Richard Peto, Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen Journal of Clinical Oncology. ,vol. 28, pp. 509- 518 ,(2010) , 10.1200/JCO.2009.23.1274

Manfred Kaufmann, Walter Jonat, Jörn Hilfrich, Holger Eidtmann, Günther Gademann, Ivan Zuna, Gunter von Minckwitz, Improved Overall Survival in Postmenopausal Women With Early Breast Cancer After Anastrozole Initiated After Treatment With Tamoxifen Compared With Continued Tamoxifen: The ARNO 95 Study Journal of Clinical Oncology. ,vol. 25, pp. 2664- 2670 ,(2007) , 10.1200/JCO.2006.08.8054